TIMELESS and neoplasm: Strikingly, the combination of TRF, TIM1 knockdown, and carboplatin also inhibited tumor growth (sh-TRF vs. sh-TIM1 + TRF + carboplatin), with this treatment displaying the most robust antitumor efficacy tendency (Fig. 8J–L).